DK3275896T3 - Fremgangsmåde til at opnå antistoffer - Google Patents
Fremgangsmåde til at opnå antistoffer Download PDFInfo
- Publication number
- DK3275896T3 DK3275896T3 DK17173501.2T DK17173501T DK3275896T3 DK 3275896 T3 DK3275896 T3 DK 3275896T3 DK 17173501 T DK17173501 T DK 17173501T DK 3275896 T3 DK3275896 T3 DK 3275896T3
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- obtaining antibodies
- antibodies
- obtaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001791.1A GB201001791D0 (en) | 2010-02-03 | 2010-02-03 | Process for obtaining antibodies |
| EP11702974.4A EP2531526B1 (en) | 2010-02-03 | 2011-02-02 | Process for obtaining antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3275896T3 true DK3275896T3 (da) | 2021-09-20 |
Family
ID=42082439
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11702974.4T DK2531526T3 (da) | 2010-02-03 | 2011-02-02 | Fremgangsmåde til opnåelse af antistoffer |
| DK17173501.2T DK3275896T3 (da) | 2010-02-03 | 2011-02-02 | Fremgangsmåde til at opnå antistoffer |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11702974.4T DK2531526T3 (da) | 2010-02-03 | 2011-02-02 | Fremgangsmåde til opnåelse af antistoffer |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US10487136B2 (da) |
| EP (2) | EP3275896B1 (da) |
| JP (2) | JP5820823B2 (da) |
| KR (1) | KR101779234B1 (da) |
| CN (1) | CN102812042B (da) |
| AU (1) | AU2011212493B2 (da) |
| BR (1) | BR112012019404B8 (da) |
| CA (1) | CA2788967C (da) |
| DK (2) | DK2531526T3 (da) |
| ES (2) | ES2886109T3 (da) |
| GB (1) | GB201001791D0 (da) |
| HU (2) | HUE055717T2 (da) |
| IL (2) | IL221266A (da) |
| LT (2) | LT3275896T (da) |
| NO (1) | NO2531526T3 (da) |
| PL (2) | PL2531526T3 (da) |
| PT (2) | PT3275896T (da) |
| SG (2) | SG10201408639RA (da) |
| SI (2) | SI3275896T1 (da) |
| WO (1) | WO2011095506A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2480661A1 (en) | 2009-09-24 | 2012-08-01 | UCB Pharma, S.A. | Bacterial host strain |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201001791D0 (en) * | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| HRP20180226T1 (hr) | 2011-07-13 | 2018-03-09 | Ucb Biopharma Sprl | Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc |
| GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
| SG11201501191XA (en) * | 2012-09-17 | 2015-04-29 | Hoffmann La Roche | Method for the production of polypeptides in the periplasm of prokaryotic cells |
| CN104004095B (zh) * | 2014-06-04 | 2016-11-23 | 博生吉医药科技(苏州)有限公司 | 一种cd7纳米抗体、其编码序列及应用 |
| KR102537099B1 (ko) | 2014-12-22 | 2023-05-25 | 유씨비 바이오파마 에스알엘 | 단백질 제조 방법 |
| BR112017013394B1 (pt) | 2014-12-22 | 2024-02-06 | Ucb Biopharma Sprl | Método para fabricar proteína de interesse |
| GB201506869D0 (en) * | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| TN2019000101A1 (en) | 2015-05-29 | 2020-07-15 | Bristol Myers Squibb Co | Antibodies against ox40 and uses thereof. |
| EP3554544A4 (en) | 2016-12-16 | 2020-07-29 | Bluefin Biomedicine, Inc. | ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE |
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CN108251523A (zh) * | 2016-12-27 | 2018-07-06 | 山东省医学科学院基础医学研究所 | 一种非小细胞肺癌分子标志物及其应用 |
| WO2018216978A1 (en) * | 2017-05-22 | 2018-11-29 | Cj Healthcare Corporation | Cell culture method at low temperature applicable to mass production of protein |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| EP0542810A1 (en) | 1990-08-02 | 1993-05-26 | B.R. Centre Limited | Methods for the production of proteins with a desired function |
| GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| GB9215540D0 (en) | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
| US5655866A (en) | 1995-03-20 | 1997-08-12 | Bellanca; Joseph V. | Method of folding a signature for use in bookbinding |
| US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| US7041479B2 (en) | 2000-09-06 | 2006-05-09 | The Board Of Trustess Of The Leland Stanford Junior University | Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| TWI334439B (en) * | 2001-08-01 | 2010-12-11 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
| CN101395269A (zh) * | 2002-10-10 | 2009-03-25 | 戴弗萨公司 | 蛋白酶、编码这些蛋白酶的核酸及它们的制备和应用方法 |
| GB0319601D0 (en) * | 2003-08-20 | 2003-09-24 | Sandoz Ag | Production process |
| GB0425534D0 (en) * | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
| US8470552B2 (en) * | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000588D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201001791D0 (en) * | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| BR112017013394B1 (pt) * | 2014-12-22 | 2024-02-06 | Ucb Biopharma Sprl | Método para fabricar proteína de interesse |
-
2010
- 2010-02-03 GB GBGB1001791.1A patent/GB201001791D0/en not_active Ceased
-
2011
- 2011-02-02 KR KR1020127022889A patent/KR101779234B1/ko active Active
- 2011-02-02 JP JP2012551605A patent/JP5820823B2/ja active Active
- 2011-02-02 WO PCT/EP2011/051450 patent/WO2011095506A1/en not_active Ceased
- 2011-02-02 DK DK11702974.4T patent/DK2531526T3/da active
- 2011-02-02 HU HUE17173501A patent/HUE055717T2/hu unknown
- 2011-02-02 CN CN201180014155.5A patent/CN102812042B/zh active Active
- 2011-02-02 SI SI201131993T patent/SI3275896T1/sl unknown
- 2011-02-02 SG SG10201408639RA patent/SG10201408639RA/en unknown
- 2011-02-02 PL PL11702974T patent/PL2531526T3/pl unknown
- 2011-02-02 LT LTEP17173501.2T patent/LT3275896T/lt unknown
- 2011-02-02 PT PT171735012T patent/PT3275896T/pt unknown
- 2011-02-02 EP EP17173501.2A patent/EP3275896B1/en active Active
- 2011-02-02 ES ES17173501T patent/ES2886109T3/es active Active
- 2011-02-02 EP EP11702974.4A patent/EP2531526B1/en active Active
- 2011-02-02 DK DK17173501.2T patent/DK3275896T3/da active
- 2011-02-02 PL PL17173501T patent/PL3275896T3/pl unknown
- 2011-02-02 HU HUE11702974A patent/HUE037191T2/hu unknown
- 2011-02-02 SG SG2012057519A patent/SG183151A1/en unknown
- 2011-02-02 LT LTEP11702974.4T patent/LT2531526T/lt unknown
- 2011-02-02 AU AU2011212493A patent/AU2011212493B2/en active Active
- 2011-02-02 NO NO11702974A patent/NO2531526T3/no unknown
- 2011-02-02 CA CA2788967A patent/CA2788967C/en active Active
- 2011-02-02 SI SI201131346T patent/SI2531526T1/sl unknown
- 2011-02-02 ES ES11702974.4T patent/ES2647387T3/es active Active
- 2011-02-02 US US13/576,980 patent/US10487136B2/en active Active
- 2011-02-02 PT PT117029744T patent/PT2531526T/pt unknown
- 2011-02-02 BR BR112012019404A patent/BR112012019404B8/pt active IP Right Grant
-
2012
- 2012-08-02 IL IL221266A patent/IL221266A/en active IP Right Grant
-
2015
- 2015-10-05 JP JP2015197399A patent/JP6141937B2/ja active Active
-
2016
- 2016-12-12 IL IL249501A patent/IL249501B/en active IP Right Grant
-
2019
- 2019-11-05 US US16/674,003 patent/US11384136B2/en active Active
-
2022
- 2022-07-06 US US17/858,112 patent/US12275777B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2300021I1 (hu) | Anti-IL-36R antitestek | |
| LTC2635601I2 (lt) | Antikūnai prieš il-23 | |
| DK3275896T3 (da) | Fremgangsmåde til at opnå antistoffer | |
| CY2017025I2 (el) | Αντιδοτα αντιπηκτικων | |
| DK3178851T3 (da) | Anti-cd40-antistoffer | |
| BR112012030311A2 (pt) | anticorpo | |
| HUE038962T2 (hu) | DLL3-ellenes antitest | |
| DK2521736T3 (da) | Humaniserede antistoffer | |
| DK3741883T3 (da) | Antistofbiblioteker | |
| BRPI1011005A2 (pt) | anticorpos anti-epcam | |
| PT2406284T (pt) | Anticorpos anti-bcma | |
| IL221719A (en) | Biomarkers for theranostics | |
| IL222272B (en) | Anti-erbb3 antibodies | |
| PL2686347T3 (pl) | Przeciwciała przeciwko CD70 | |
| CR20130228A (es) | Anticuerpos neutralizadores anti-ccl20 | |
| DK3284754T3 (da) | Anti-cd38-antistoffer | |
| CO6791565A2 (es) | Anticuerpos anti-notch1 | |
| EP2629796A4 (en) | ANTIBODY | |
| DK2564396T3 (da) | Fremgangsmåde til isotop-fremstilling | |
| DK3985979T3 (da) | Fremgangsmåde til bestemmelse af referenceenhed | |
| DK2595948T3 (da) | Fremgangsmåde til fremstilling af ingenol-3-angelat | |
| DK2593797T3 (da) | Hidtil ukendte fremgangsmåder til proteinevolution | |
| CO6841994A2 (es) | Anticuerpos | |
| DK2558473T3 (da) | Fremgangsmåde til fremstilling af dithiin-tetracarboximider | |
| DK2655360T3 (da) | Fremgangsmåde til fremstilling af n-sulfonylsubstituerede oxindoler |